Synchron today presented the first-ever public demonstration of an individual using an Apple iPad controlled entirely by ...

Getinge announced today that European regulatory authorities reinstated the CE mark for its Cardiosave intra-aortic balloon ...

Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB).

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

Orchestra BioMed (Nasdaq:OBIO) today announced the pricing of an underwritten public offering totaling proceeds of ...

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Baxter (NYSE: BAX) + shares fell sharply today on second-quarter results that came up shy of the consensus forecast. Shares ...

Stryker will increase its full-year guidance after a Street-beating second quarter that saw strong demand for products and continued business momentum.

Vicarious Surgical (NYSE:RBOT) announced today that it appointed Stephen From as CEO, effective Aug. 7, 2025. Adam Sachs, ...

Resmed (NYSE: RMD) today reported second-quarter financial results that came in ahead of the consensus Wall Street forecast.

Integra LifeSciences (Nasdaq: IART) shares are on the rise today on second-quarter results that beat the consensus forecast.

Sava Technologies could be bringing another glucose biosensor to the competitive continuous glucose monitor (CGM) market.